News | News By Subject | News by Disease News By Date | Search News

Dermatitis News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Regeneron (REGN), Sanofi (SNY) Tout Phase III Dupixent Data     10/3/2016
Pfizer (PFE) Shows Off Final Data from Two Late-Stage Dermatitis Studies     7/13/2016
Regeneron (REGN) and Sanofi (SNY)'s Dermatitis Drug Meets Goals in Late-Stage Study     6/6/2016
Regeneron (REGN), Sanofi (SNY)'s Eczema Drug Clears Hurdles in Huge Late-Stage Studies     4/1/2016
Aquinox (AQXP)'s AQX-1125 Flunks Mid Stage Study for Patients With Atopic Dermatitis     11/3/2015
Anacor (ANAC) Hits Home Run with Crisaborole Phase III Trials, Predicts $1 Billion Potential Sales     7/15/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Regeneron (REGN), ReGen Therapeutics Plc (RGT.L) Eczema Drug Dupilumab Gets FDA Breakthrough Therapy Designation     11/24/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Regeneron Pharmaceuticals, Inc. (REGN), Sanofi (France) (SAN.PA) Drug Tames Eczema In Phase 2b Trial     7/10/2014
Sanofi (France) (SAN.PA), Regeneron Pharmaceuticals, Inc. (REGN) Hail Results of Dermatitis Study     3/4/2013
Anacor Pharmaceuticals, Inc. Reports Positive Preliminary Results From Two Safety Studies Of AN2728     2/7/2012
Galderma Pharma S.A. Announces Positive Phase 2b Results for Investigational Compound Targeting Redness of Rosacea     10/20/2011
Pfizer Inc. (PFE) Receives Approvable Letter from FDA for Dalbavancin     12/26/2007

News from Around the Web
Hand Washing Focus In Hospitals Has Led To Rise In Worker Dermatitis, University of Manchester Study     2/13/2015
Brief Stress May Be Good For Your Skin, University of California, San Francisco (UCSF) Study     8/8/2014
Lower Occurrence of Atopic Dermatitis in Children Thanks to Farm Animals and Cats, University of Zurich Study     12/3/2010
Hold the Lime with Corona, May Cause Skin Reaction, Doctor Finds at Archives of Dermatology     10/19/2010
Drug Used To Treat Skin Conditions Is A Marine Pollutant, University of Gothenburg Study     3/24/2009
Bone Marrow-Derived Stem Cells May Offer Novel Therapeutic Option For Skin Disorder, University of Minnesota Study     12/5/2008
Combination of Limes, Sun Can Result in 'Margarita Dermatitis'     8/16/2007
Glucocorticoid Plays Key Role In Skin Abnormalities Induced By Psychological Stress     12/1/2006
Steroid Lotion Effective For Eczema In Young Kids     5/1/2006
Cephalon, Inc. (CEPH) Drug A Victim Of ADHD Debate: Experts     3/30/2006
Kikkoman, Tohoku University Confirm That Tomato Extract Helps Heal Atopic Dermatitis     3/10/2006
Top 10 Causes Of Skin Allergy     3/9/2006
Delaying Solid Food By 6m Doesn't Prevent Allergy     2/21/2006
Corticosteroids Can Contribute To Osteoporosis     1/19/2006
Xolair "Add-On" Helpful In Uncontrolled Dermatitis     1/13/2006

Press Releases
Helsinn Integrative Care Wins FDA Nod for Medical Device Xonrid Gel     12/1/2016
Dermata Therapeutics Announces Initiation Of Treatment In A Phase 2 Atopic Dermatitis Study     11/17/2016
Santalis Obtains FDA Allowance To Start A Phase 2 Clinical Study For The Treatment Of Mild To Moderate Atopic Dermatitis (AD)     11/3/2016
One Out of the Two Reasons Allergan (AGN) Paid $640 Million for Vitae Pharma (VTAE) Just Flunked Mid-Stage Test     11/3/2016
Regeneron (REGN) Could Have Another Blockbuster in This Drug     10/10/2016
MorphoSys AG And Galapagos (GLPG.BR) Start First-In-Patient Dosing of IL-17C Antibody MOR106 In Atopic Dermatitis     9/29/2016
Regeneron (REGN) And Sanofi (SNY) Announce Dupilumab Biologics License Application Accepted For Priority Review By U.S. FDA     9/26/2016
Santalis Initiates A Phase II Study Of Mild, Moderate And Severe Atopic Dermatitis - Enrolls First Patient Into Its Australian Clinical Trial Site     9/6/2016
Kindred Bio (KIN) Announces Initiation Of Pilot Field Study Of Atopic Dermatitis And Other Updates     6/15/2016
PuriCore Successfully Completes Pre-IND Meeting With The FDA On PR022 For Atopic Dermatitis     6/9/2016
Medimetriks Pharmaceuticals, Inc. Announces The Results Of A Successful Phase 2 Trial Of MM36 In Atopic Dermatitis; Study Results And Design Published In The Journal Of The American Academy Of Dermatology (JAAD)     5/23/2016
Provectus Announces Abstract Available Online Of Trials In Progress; Abstract For Poster Presentation At ASCO Annual Meeting     5/19/2016
Incyte (INCY) Reports 2016 First-Quarter Financial Results And Updates Shareholders On Key Clinical Programs     5/9/2016
Regeneron (REGN) Reports First Quarter 2016 Financial And Operating Results     5/5/2016
Cipher Pharma (DND.TO) Announces Approvals Of Astion Acquired Barrier Creams By Health Canada And The Medicines Evaluation Board     4/7/2016

//-->